Microcarriers Market Size Set to Expand to USD 4.17 Billion by 2030, Driven by Cell Therapy Demand and Strategic Innovations - The Insight Partners
The microcarriers market is projected to grow from USD 1.62 Billion in 2022 to USD 4.17 Billion by 2030, driven by rising ...
Intelligent Bio Solutions secures U.S. patent, strengthening IP protection
Intelligent Bio Solutions (INBS) announced that the Company has been granted a patent in the United States relating to its Intelligent ...
Taiwan News1d
Fungicides Market to Reach $25.1 Billion by 2030, Growing at a 5.1% CAGR
The global fungicides market size was US$ 17.3 billion in 2021. The global fungicides market is forecast to grow to US$ 25.1 billion in 2030 by registering a compound annual growth rate (CAGR) of 5.1% ...
Taiwan News3d
Transplant Diagnostics Market to Reach $6.4 Billion by 2028, Growing at a 7.4% CAGR
The global transplant diagnostics market, valued at USD 3.9 billion in 2021, is anticipated to grow at a CAGR of 7.40%, reaching approximately USD 6.4 billion by 2028. This growth is driven by ...
Carbon Capture Construction Materials Market To Reach USD 961.68 Million By 2034, Booming At An Exceptional 42.5% CAGR
Carbon Capture Construction Materials Market The role of carbon-infused concrete, biochar-based composites, and recycled aggregates in miti ...
Newborn Screening Market Size to Reach US$ 2.69 billion by 2031, Growing at a CAGR of 9.5%, Says The Insight Partners
The Newborn Screening Market growth is driven by increasing government funding for screening programs, advancements in ...
Zacks Investment Research on MSN1d
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
Intelligent Bio Solutions Inc. INBS recently announced that it has secured a key patent in the United States relating to the ...
Precision Fermentation Market is expected to generate a revenue of USD 34.2 Billion by 2031, Globally, at 40.1% CAGR: Verified Market Research®
Precision fermentation is revolutionizing the food and biotechnology industries by enabling the production of high-value ingredients, alternative proteins, and bio-based compounds. Leveraging ...
INmune Bio, Inc.: INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...
eLife16h
Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.